Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study

Roberto Mina; Angelo Belotti; Maria Teresa Petrucci; Renato Zambello; Andrea Capra; Giacomo Di Lullo; Sonia Ronconi; Norbert Pescosta; Mariella Grasso; Federico Monaco; Claudia Cellini; Marco Gobbi; Stelvio Ballanti; Paolo de Fabritiis; Maria Letizia Mosca-Siez; Monia Marchetti; Anna Marina Liberati; Massimo Offidani; Nicola Giuliani; Roberto Ria; Pellegrino Musto; Alessandra Romano; Pieter Sonneveld; Mario Boccadoro; Alessandra Larocca

doi:10.1038/s41408-020-0326-1

Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study

Roberto Mina, Angelo Belotti, Maria Teresa Petrucci, Renato Zambello, Andrea Capra, Giacomo Di Lullo, Sonia Ronconi, Norbert Pescosta, Mariella Grasso, Federico Monaco, Claudia Cellini, Marco Gobbi, Stelvio Ballanti, Paolo de Fabritiis, Maria Letizia Mosca-Siez, Monia Marchetti, Anna Marina Liberati, Massimo Offidani, Nicola Giuliani, Roberto RiaPellegrino Musto, Alessandra Romano, Pieter Sonneveld, Mario Boccadoro, Alessandra Larocca

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	58
Journal	Blood Cancer J.
Volume	10
Issue number	5
DOIs	https://doi.org/10.1038/s41408-020-0326-1
Publication status	Published - May 18 2020

Access to Document

10.1038/s41408-020-0326-1

Cite this

Mina, R., Belotti, A., Petrucci, M. T., Zambello, R., Capra, A., Di Lullo, G., Ronconi, S., Pescosta, N., Grasso, M., Monaco, F., Cellini, C., Gobbi, M., Ballanti, S., de Fabritiis, P., Mosca-Siez, M. L., Marchetti, M., Liberati, A. M., Offidani, M., Giuliani, N., ... Larocca, A. (2020). Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study. Blood Cancer J., 10(5), 58. https://doi.org/10.1038/s41408-020-0326-1

Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study. / Mina, Roberto; Belotti, Angelo; Petrucci, Maria Teresa; Zambello, Renato; Capra, Andrea; Di Lullo, Giacomo; Ronconi, Sonia; Pescosta, Norbert; Grasso, Mariella; Monaco, Federico; Cellini, Claudia; Gobbi, Marco; Ballanti, Stelvio; de Fabritiis, Paolo; Mosca-Siez, Maria Letizia; Marchetti, Monia; Liberati, Anna Marina; Offidani, Massimo; Giuliani, Nicola; Ria, Roberto; Musto, Pellegrino; Romano, Alessandra; Sonneveld, Pieter; Boccadoro, Mario; Larocca, Alessandra.

In: Blood Cancer J., Vol. 10, No. 5, 18.05.2020, p. 58.

Research output: Contribution to journal › Article › peer-review

Mina, R, Belotti, A, Petrucci, MT, Zambello, R, Capra, A, Di Lullo, G, Ronconi, S, Pescosta, N, Grasso, M, Monaco, F, Cellini, C, Gobbi, M, Ballanti, S, de Fabritiis, P, Mosca-Siez, ML, Marchetti, M, Liberati, AM, Offidani, M, Giuliani, N, Ria, R, Musto, P, Romano, A, Sonneveld, P, Boccadoro, M & Larocca, A 2020, 'Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study', Blood Cancer J., vol. 10, no. 5, pp. 58. https://doi.org/10.1038/s41408-020-0326-1

Mina, Roberto ; Belotti, Angelo ; Petrucci, Maria Teresa ; Zambello, Renato ; Capra, Andrea ; Di Lullo, Giacomo ; Ronconi, Sonia ; Pescosta, Norbert ; Grasso, Mariella ; Monaco, Federico ; Cellini, Claudia ; Gobbi, Marco ; Ballanti, Stelvio ; de Fabritiis, Paolo ; Mosca-Siez, Maria Letizia ; Marchetti, Monia ; Liberati, Anna Marina ; Offidani, Massimo ; Giuliani, Nicola ; Ria, Roberto ; Musto, Pellegrino ; Romano, Alessandra ; Sonneveld, Pieter ; Boccadoro, Mario ; Larocca, Alessandra. / Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study. In: Blood Cancer J. 2020 ; Vol. 10, No. 5. pp. 58.

@article{4057e7410fe9425aa35885035acde338,

title = "Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study",

author = "Roberto Mina and Angelo Belotti and Petrucci, {Maria Teresa} and Renato Zambello and Andrea Capra and {Di Lullo}, Giacomo and Sonia Ronconi and Norbert Pescosta and Mariella Grasso and Federico Monaco and Claudia Cellini and Marco Gobbi and Stelvio Ballanti and {de Fabritiis}, Paolo and Mosca-Siez, {Maria Letizia} and Monia Marchetti and Liberati, {Anna Marina} and Massimo Offidani and Nicola Giuliani and Roberto Ria and Pellegrino Musto and Alessandra Romano and Pieter Sonneveld and Mario Boccadoro and Alessandra Larocca",

year = "2020",

month = may,

day = "18",

doi = "10.1038/s41408-020-0326-1",

language = "English",

volume = "10",

pages = "58",

journal = "Blood Cancer J.",

issn = "2044-5385",

publisher = "Springer Nature",

number = "5",

}

TY - JOUR

T1 - Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study

AU - Mina, Roberto

AU - Belotti, Angelo

AU - Petrucci, Maria Teresa

AU - Zambello, Renato

AU - Capra, Andrea

AU - Di Lullo, Giacomo

AU - Ronconi, Sonia

AU - Pescosta, Norbert

AU - Grasso, Mariella

AU - Monaco, Federico

AU - Cellini, Claudia

AU - Gobbi, Marco

AU - Ballanti, Stelvio

AU - de Fabritiis, Paolo

AU - Mosca-Siez, Maria Letizia

AU - Marchetti, Monia

AU - Liberati, Anna Marina

AU - Offidani, Massimo

AU - Giuliani, Nicola

AU - Ria, Roberto

AU - Musto, Pellegrino

AU - Romano, Alessandra

AU - Sonneveld, Pieter

AU - Boccadoro, Mario

AU - Larocca, Alessandra

PY - 2020/5/18

Y1 - 2020/5/18

U2 - 10.1038/s41408-020-0326-1

DO - 10.1038/s41408-020-0326-1

M3 - Article

C2 - 32424154

VL - 10

SP - 58

JO - Blood Cancer J.

JF - Blood Cancer J.

SN - 2044-5385

IS - 5

ER -